Skip to main content
. 2021 Aug 10;22(4):725. doi: 10.3892/ol.2021.12986

Table I.

Blood biochemical examination results of subjects.

GC Pre NC
Variables No. of patients Mean ± SD No. of patients Mean ± SD No. of patients Mean ± SD P-valuea GC vs. Pre P-value GC vs. NC P-value Pre vs. NC P-value
WBC, 109/l 89 6.41±2.98 76 6.25±2.68 45 6.01±1.28 0.2846 – – –
N#, 109/l 89 4.55±2.86 76 3.84±2.61 45 3.61±0.98 0.0445 >0.999 0.039 0.228
L#, 109/l 89 1.34±0.66 76 1.66±0.76 45 1.93±0.73 <0.0001 0.002 0.001 0.169
M#, 109/l 89 0.31±0.21 76 0.31±0.17 45 0.24±0.4 0.0018 >0.999 0.002 0.015
N% 89 67.81±14.75 76 63.45±12.65 45 61.23±7.99 0.0003 0.052 0.001 0.260
L% 89 22.74±11.4 76 29.31±11.63 45 31.90±7.57 <0.0001 0.025 0.016 0.001
M% 89 5.31±3.75 76 5.05±2.17 45 3.71±1.35 0.0003 0.237 0.001 0.023
Hb, g/l 89 116.10±32.22 76 128.04±21.67 45 138.46±16.05 <0.0001 0.001 0.01 0.001
Hct, % 89 35.70±9.07 76 39.21±6.18 45 40.43±3.92 <0.0001 0.001 0.001 >0.999
RDW-CV, % 89 14.01±3.24 76 12.75±1.92 45 12.31±1.40 <0.0001 0.001 0.001 0.048
PLT, 1012/l 89 256.00±111.43 76 231.50±63.38 45 248.00±54.68 0.0704 – – –
PDW, % 89 11.65±2.77 76 11.91±2.51 45 15.90±0.38 <0.0001 >0.999 0.001 0.001
MPV, fl 89 9.62±1.20 76 9.91±1.14 45 8.90±1.39 <0.0001b 0.046 0.003 0.001
MPV/PC 89 0.04±0.04 76 0.04±0.02 45 0.03±0.01 0.0047 0.105 0.428 0.004
MLR 89 0.24±0.41 76 0.17±0.18 45 0.11±0.98 <0.0001 0.006 0.001 0.003
NLR 89 2.94±9.33 76 2.20±6.09 45 1.96±0.63 <0.0001 0.001 0.001 0.001
PLR 89 198.05±286.52 76 131.03±112.07 45 134.36±76.12 <0.0001 0.001 0.001 0.031
CA125, U/ml 68 59.22±92.72 53 12.36±7.78 45 11.07±4.05 0.0078 0.024 0.028 >0.999
CA211, ng/ml 40 16.15±44.84 62 2.95±1.38 45 2.09±0.48 <0.0001 0.045 0.001 0.001
CA50, U/ml 48 38.01±99.02 77 8.18±5.97 34 4.91±4.46 <0.0001 0.001 0.001 0.001
a

P-values indicated for differences among three groups.

b

The only P-value calculated using ANOVA while all other P-values were calculated using Kruskal-Wallis. P<0.05 was considered to indicate a statistically significant difference. Some data are missing due to retrospective data collection. GC, gastric cancer; Pre, precancerous lesions; NC, healthy control; WBC, white blood cell count; N#, neutrophil count; L#, lymphocyte count; M#, monocyte count; N%, neutrophil percentage; L%, lymphocyte percentage; M%, monocyte percentage; Hb, hemoglobin; Hct, hematocrit; RDW-CV, red blood cell distribution width-coefficient of variation; PLT, platelet count; PDW, platelet distribution width; MPV, mean platelet volume; MPV/PC, mean platelet volume/platelet count ratio; MLR, monocyte to lymphocyte count ratio; NLR, neutrophil to lymphocyte ratio; PLR, platelet to lymphocyte count ratio.